カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

卵管がん治療薬の世界市場2024～2028

■ 英語タイトル：Global Fallopian Tube Cancer Therapeutics Market 2024-2028

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR73559-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR73559-23
■ 発行日：2023年10月11日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医療
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[卵管がん治療薬の世界市場2024～2028]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

卵管がん治療薬の世界市場 2024〜2028年卵管がん治療薬市場は2023-2028年に8億3,201万米ドルで成長し、予測期間中のCAGRは10.35%で加速すると予測されます。当レポートでは、卵管がん治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを提供しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、女性の健康に対する関心の高まり、強力な医薬品承認の数々、婦人科系がんに対する意識の高まりによって牽引されています。

Technavio社の卵管がん治療薬市場は以下のように分類されています。
エンドユーザー別
- 病院
- 診療所およびASC
- その他

製品別
- 標的療法
- 化学療法

地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）

本調査では、今後数年間の卵管がん治療薬市場の成長を促進する主な理由の一つとして、再生療法に関する研究の拡大を挙げています。また、癌の治療ワクチンの登場や、効果的な治療のためのナノテクノロジーの利用拡大も、市場の大きな需要につながるでしょう。

この調査レポートは、卵管がん治療薬市場を分析・予測し、以下の市場分野についての調査結果を掲載しています。
- 卵管がん治療薬市場規模
- 卵管がん治療薬市場予測
- 卵管がん治療薬市場の産業分析

強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc、 Arrien Pharmaceuticals LLC、AstraZeneca Plc、Baxter International Inc.、BioVaxys Technology Corp.、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、Clinigen Group Plc、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、ImmunoGen Inc.、Johnson and Johnson、Merck and Co. Inc.、Novartis AG、Pfizer Inc.、Siemens Healthineers AG、Sun Pharmaceutical Industries Ltd.、Clovis Oncology Inc.などの企業情報が含まれています。また、卵管がん治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 卵管がん治療薬の世界市場：エンドユーザー別市場分析
7 卵管がん治療薬の世界市場：製品別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global fallopian tube cancer therapeutics market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global fallopian tube cancer therapeutics market 2018 – 2022 ($ million)
o 4.2 End-user Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
o 4.3 Product Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user – Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals – Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospitals – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Hospitals – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Hospitals – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospitals – Year-over-year growth 2023-2028 (%)
o 6.4 Clinics and ASCs – Market size and forecast 2023-2028
o Exhibit 38: Chart on Clinics and ASCs – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Clinics and ASCs – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Clinics and ASCs – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Clinics and ASCs – Year-over-year growth 2023-2028 (%)
o 6.5 Others – Market size and forecast 2023-2028
o Exhibit 42: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product – Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Targeted therapy – Market size and forecast 2023-2028
o Exhibit 52: Chart on Targeted therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Targeted therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Targeted therapy – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Targeted therapy – Year-over-year growth 2023-2028 (%)
o 7.4 Chemotherapy – Market size and forecast 2023-2028
o Exhibit 56: Chart on Chemotherapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Chemotherapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Chemotherapy – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Chemotherapy – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 67: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 83: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.10 Canada – Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.11 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. – Overview
o Exhibit 112: AbbVie Inc. – Product / Service
o Exhibit 113: AbbVie Inc. – Key news
o Exhibit 114: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 115: Amgen Inc. – Overview
o Exhibit 116: Amgen Inc. – Product / Service
o Exhibit 117: Amgen Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 118: AstraZeneca Plc – Overview
o Exhibit 119: AstraZeneca Plc – Product / Service
o Exhibit 120: AstraZeneca Plc – Key news
o Exhibit 121: AstraZeneca Plc – Key offerings
o 12.6 Baxter International Inc.
o Exhibit 122: Baxter International Inc. – Overview
o Exhibit 123: Baxter International Inc. – Business segments
o Exhibit 124: Baxter International Inc. – Key news
o Exhibit 125: Baxter International Inc. – Key offerings
o Exhibit 126: Baxter International Inc. – Segment focus
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 127: Boehringer Ingelheim International GmbH – Overview
o Exhibit 128: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 129: Boehringer Ingelheim International GmbH – Key news
o Exhibit 130: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 131: Boehringer Ingelheim International GmbH – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 132: Bristol Myers Squibb Co. – Overview
o Exhibit 133: Bristol Myers Squibb Co. – Product / Service
o Exhibit 134: Bristol Myers Squibb Co. – Key news
o Exhibit 135: Bristol Myers Squibb Co. – Key offerings
o 12.9 Clovis Oncology Inc.
o Exhibit 136: Clovis Oncology Inc. – Overview
o Exhibit 137: Clovis Oncology Inc. – Product / Service
o Exhibit 138: Clovis Oncology Inc. – Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 139: Eli Lilly and Co. – Overview
o Exhibit 140: Eli Lilly and Co. – Product / Service
o Exhibit 141: Eli Lilly and Co. – Key news
o Exhibit 142: Eli Lilly and Co. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 143: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 144: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 145: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 146: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 147: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 148: GlaxoSmithKline Plc – Overview
o Exhibit 149: GlaxoSmithKline Plc – Business segments
o Exhibit 150: GlaxoSmithKline Plc – Key news
o Exhibit 151: GlaxoSmithKline Plc – Key offerings
o Exhibit 152: GlaxoSmithKline Plc – Segment focus
o 12.13 ImmunoGen Inc.
o Exhibit 153: ImmunoGen Inc. – Overview
o Exhibit 154: ImmunoGen Inc. – Product / Service
o Exhibit 155: ImmunoGen Inc. – Key offerings
o 12.14 Johnson and Johnson
o Exhibit 156: Johnson and Johnson – Overview
o Exhibit 157: Johnson and Johnson – Business segments
o Exhibit 158: Johnson and Johnson – Key news
o Exhibit 159: Johnson and Johnson – Key offerings
o Exhibit 160: Johnson and Johnson – Segment focus
o 12.15 Merck and Co. Inc.
o Exhibit 161: Merck and Co. Inc. – Overview
o Exhibit 162: Merck and Co. Inc. – Business segments
o Exhibit 163: Merck and Co. Inc. – Key news
o Exhibit 164: Merck and Co. Inc. – Key offerings
o Exhibit 165: Merck and Co. Inc. – Segment focus
o 12.16 Novartis AG
o Exhibit 166: Novartis AG – Overview
o Exhibit 167: Novartis AG – Business segments
o Exhibit 168: Novartis AG – Key offerings
o Exhibit 169: Novartis AG – Segment focus
o 12.17 Pfizer Inc.
o Exhibit 170: Pfizer Inc. – Overview
o Exhibit 171: Pfizer Inc. – Product / Service
o Exhibit 172: Pfizer Inc. – Key news
o Exhibit 173: Pfizer Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global fallopian tube cancer therapeutics market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on End-user – Market share 2023-2028 (%)
Exhibits31: Data Table on End-user – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Hospitals – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Hospitals – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinics and ASCs – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Clinics and ASCs – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Clinics and ASCs – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinics and ASCs – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product – Market share 2023-2028 (%)
Exhibits49: Data Table on Product – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Targeted therapy – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Targeted therapy – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Targeted therapy – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Targeted therapy – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Chemotherapy – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Chemotherapy – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Chemotherapy – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Chemotherapy – Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. – Overview
Exhibits112: AbbVie Inc. – Product / Service
Exhibits113: AbbVie Inc. – Key news
Exhibits114: AbbVie Inc. – Key offerings
Exhibits115: Amgen Inc. – Overview
Exhibits116: Amgen Inc. – Product / Service
Exhibits117: Amgen Inc. – Key offerings
Exhibits118: AstraZeneca Plc – Overview
Exhibits119: AstraZeneca Plc – Product / Service
Exhibits120: AstraZeneca Plc – Key news
Exhibits121: AstraZeneca Plc – Key offerings
Exhibits122: Baxter International Inc. – Overview
Exhibits123: Baxter International Inc. – Business segments
Exhibits124: Baxter International Inc. – Key news
Exhibits125: Baxter International Inc. – Key offerings
Exhibits126: Baxter International Inc. – Segment focus
Exhibits127: Boehringer Ingelheim International GmbH – Overview
Exhibits128: Boehringer Ingelheim International GmbH – Business segments
Exhibits129: Boehringer Ingelheim International GmbH – Key news
Exhibits130: Boehringer Ingelheim International GmbH – Key offerings
Exhibits131: Boehringer Ingelheim International GmbH – Segment focus
Exhibits132: Bristol Myers Squibb Co. – Overview
Exhibits133: Bristol Myers Squibb Co. – Product / Service
Exhibits134: Bristol Myers Squibb Co. – Key news
Exhibits135: Bristol Myers Squibb Co. – Key offerings
Exhibits136: Clovis Oncology Inc. – Overview
Exhibits137: Clovis Oncology Inc. – Product / Service
Exhibits138: Clovis Oncology Inc. – Key offerings
Exhibits139: Eli Lilly and Co. – Overview
Exhibits140: Eli Lilly and Co. – Product / Service
Exhibits141: Eli Lilly and Co. – Key news
Exhibits142: Eli Lilly and Co. – Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. – Overview
Exhibits144: F. Hoffmann La Roche Ltd. – Business segments
Exhibits145: F. Hoffmann La Roche Ltd. – Key news
Exhibits146: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits148: GlaxoSmithKline Plc – Overview
Exhibits149: GlaxoSmithKline Plc – Business segments
Exhibits150: GlaxoSmithKline Plc – Key news
Exhibits151: GlaxoSmithKline Plc – Key offerings
Exhibits152: GlaxoSmithKline Plc – Segment focus
Exhibits153: ImmunoGen Inc. – Overview
Exhibits154: ImmunoGen Inc. – Product / Service
Exhibits155: ImmunoGen Inc. – Key offerings
Exhibits156: Johnson and Johnson – Overview
Exhibits157: Johnson and Johnson – Business segments
Exhibits158: Johnson and Johnson – Key news
Exhibits159: Johnson and Johnson – Key offerings
Exhibits160: Johnson and Johnson – Segment focus
Exhibits161: Merck and Co. Inc. – Overview
Exhibits162: Merck and Co. Inc. – Business segments
Exhibits163: Merck and Co. Inc. – Key news
Exhibits164: Merck and Co. Inc. – Key offerings
Exhibits165: Merck and Co. Inc. – Segment focus
Exhibits166: Novartis AG – Overview
Exhibits167: Novartis AG – Business segments
Exhibits168: Novartis AG – Key offerings
Exhibits169: Novartis AG – Segment focus
Exhibits170: Pfizer Inc. – Overview
Exhibits171: Pfizer Inc. – Product / Service
Exhibits172: Pfizer Inc. – Key news
Exhibits173: Pfizer Inc. – Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 吸入麻酔の世界市場2024～2028
  • 溶接用呼吸器システムの世界市場2024-2028
  • ニューロモーフィックコンピューティングの世界市場2024～2028
  • 勃起不全（ED）治療薬の世界市場2024～2028
  • 医療用吸引器の世界市場2024-2028
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR73559-23 )"卵管がん治療薬の世界市場2024～2028" (英文：Global Fallopian Tube Cancer Therapeutics Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。